《【美国减肥药物制造商】Allurion Technologies, Inc.（ALUR）美股IPO招股说明书 S-1（修订版）（英文版）（288页）.pdf》由会员分享，可在线阅读，更多相关《【美国减肥药物制造商】Allurion Technologies, Inc.（ALUR）美股IPO招股说明书 S-1（修订版）（英文版）（288页）.pdf（288页珍藏版）》请在三个皮匠报告上搜索。

1、Table of ContentsAs filed with the Securities and Exchange Commission on January 13,2025.Registration No.333-283701 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 Amendment No.2toFORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933 ALLURION TECHNOLOGIES,INC.(Exact name

2、of registrant as specified in its charter)Delaware 3841 92-2182207(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification No.)11 Huron DriveNatick,MA 01760(508)647-4000(Address,including zip code,and telephone

3、number,including area code,of registrants principal executive offices)Shantanu GaurChief Executive OfficerAllurion Technologies,Inc.11 Huron DriveNatick,MA 01760Telephone:(508)647-4000(Name,address,including zip code,and telephone number,including area code,of agent for service)Copies to:Danielle M.

4、LauzonJeffrey A.LetalienPaul R.RosieGoodwin Procter LLP100 Northern AvenueBoston,MA 02210(617)570-1000 Brendan GibbonsChief Legal OfficerAllurion Technologies,Inc.11 Huron DriveNatick,MA 01760(508)647-4000 Charles PhillipsEllenoff Grossman&Schole LLP1345 Avenue of the AmericasNew York,NY 10105(212)3

5、70-1300 Approximate date of commencement of proposed sale to the public:From time to time after this Registration Statement becomes effective.If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 193

6、3 check thefollowing box:If this form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,check the following box and list the Securities Actregistration statement number of the earlier effective registration statement for the same offering.If t